This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Under-the-Radar Health Stocks for Today

"Under-the-Radar Stocks" is a daily feature that uncovers little-known companies worthy of investors' consideration. Check in at 5 a.m. every morning to find out about stocks that tend to beat their bigger brethren.

The Vanguard Health Care Index has declined 1% this year as investors are more interested in buying beaten-down technology stocks. The Nasdaq, a barometer for tech shares, has increased 15%.

But some health-care companies are poised for strong revenue and earnings growth. In addition, as the stock market rebounds and credit gets easier, micro-cap health-care suppliers like the two listed below may become acquisition targets.

TheStreet.com Ratings

Allen, Texas-based Atrion Corp. (ATRI - Get Report) develops and sells products and components for the health-care industry. Products range from cardiovascular to ophthalmology, and the company also makes a line of non-medical components for aviation and marine safety. TheStreet.com Ratings has given Atrion a "buy" rating for two years.

During the first quarter, revenue rose a marginal 1.8% to $25 million, but earnings per share climbed 13% to $2.06. The company managed to improve upon its strong financial position by adding $16 million to the cash balance while retaining its debt-free status.

Looking at peer valuation in the health-care-supplies industry, Atrion is trading at a discount based on earnings, sales, book value and cash flow. With a price-to-earnings ratio of 14.91, Atrion is 27% cheaper than its average peer. The stock, which offers a 1% dividend yield, has increased 22% this year.

Like Atrion, Merit Medical Systems (MMSI - Get Report) is a top-rated micro-cap. The South Jordan, Utah-based company, which manufactures disposable medical devices for diagnosis, radiology and cardiology, was upgraded to "buy" on May 27 after posting strong first-quarter results. Merit Medical Systems has achieved year-over-year earnings per share growth for nine consecutive quarters.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
ATRI $328.00 0.00%
MMSI $19.92 0.00%
AAPL $128.70 0.00%
FB $78.81 0.00%
GOOG $540.78 0.00%

Markets

DOW 18,070.40 +46.34 0.26%
S&P 500 2,114.49 +6.20 0.29%
NASDAQ 5,016.9290 +11.5380 0.23%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs